The current situation of the levonorgestrel intrauterine system (LNG-IUS) in conservative treatment for patients with early-stage endometrial cancer and atypical hyperplasia

被引：10
|
作者：
Chen, Xiaojun [1 ,2 ]
机构：
[1] Fudan Univ, Dept Gynecol, Obstet & Gynecol Hosp, 419 Fangxie Rd, Shanghai 200011, Peoples R China
[2] Shanghai Key Lab Female Reprod Endocrine Related, Shanghai, Peoples R China
来源：
JOURNAL OF GYNECOLOGIC ONCOLOGY | 2019年 / 30卷 / 04期
关键词：
MANAGEMENT; WOMEN;
D O I：
10.3802/jgo.2019.30.e79
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Comparison of Mirena and Liletta levonorgestrel intrauterine device for the treatment of endometrial intraepithelial neoplasia and low risk early-stage endometrial cancer
    Chaudhari, Sonal
    Lai, Tiffany
    Zakhour, Mae
    Baltayan, Armine
    Tan, Hongying Tina
    Sim, Myung-Shin
    Cohen, Joshua
    GYNECOLOGIC ONCOLOGY, 2023, 176 : S129 - S129
  • [42] Current research of Assisted Reproductive Technology for women with early endometrial cancer and atypical endometrial hyperplasia after conservative treatment
    Jiang, Yan-le
    Lin, Yan-ying
    Chen, Chen-xi
    Li, Yu-xin
    Xie, Huang-yan
    Zheng, Bei-hong
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [43] CONSERVATIVE TREATMENT OF ATYPICAL ENDOMETRIAL HYPERPLASIA AND EARLY ENDOMETRIAL CANCER: A PROSPECTIVE SINGLE INSTITUTION STUDY OF 418 PATIENTS
    Novikova, O.
    Novikova, E.
    Nosov, V.
    Shevchuk, A.
    Avasova, C.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A5 - A6
  • [44] Analysis of assisted reproductive outcomes in patients with atypical endometrial hyperplasia and early-stage endometrial cancer after fertility-sparing treatment
    Li, Jiaheng
    Li, Mengnuo
    Li, Yijiang
    Zhao, Xianling
    Guan, Yichun
    Yuan, Xiaoqiong
    Du, Shanshan
    Zhang, Caihua
    Liu, Wenxia
    Ren, Bingnan
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2025, 168 (02) : 598 - 604
  • [45] Comparison of Levonorgestrel-releasing Intrauterine System (LNG-IUS) against Laparoscopic Assisted Supracervical Hysterectomy (LASH) for menorrhagia treatment: An economic evaluation
    Laughton, Matthew
    Patel, Natasha Chandrakant
    Dawoodbhoy, Fatema Mustansir
    El-Ghrably, Salma
    Mahmud, Saheel
    JOURNAL OF GYNECOLOGY OBSTETRICS AND HUMAN REPRODUCTION, 2021, 50 (10)
  • [46] Treatment of Low-Risk Endometrial Cancer and Complex Atypical Hyperplasia With the Levonorgestrel-Releasing Intrauterine Device
    Pal, Navdeep
    Broaddus, Russell R.
    Urbauer, Diana L.
    Balakrishnan, Nyla
    Milbourne, Andrea
    Schmeler, Kathleen M.
    Meyer, Larissa A.
    Soliman, Pamela T.
    Lu, Karen H.
    Ramirez, Pedro T.
    Ramondetta, Lois
    Bodurka, Diane C.
    Westin, Shannon N.
    OBSTETRICS AND GYNECOLOGY, 2018, 131 (01): : 109 - 116
  • [47] Treatment of Low-Risk Endometrial Cancer and Complex Atypical Hyperplasia With the Levonorgestrel-Releasing Intrauterine Device
    Penick, Emily
    OBSTETRICS AND GYNECOLOGY, 2018, 131 (04): : 737 - 738
  • [48] Conservative management of endometrial hyperplasia/carcinoma with levonorgestrel intrauterine system may be less effective in patients with morbid obesity
    Graul, A.
    Haggerty, A. F.
    Reed, H.
    Kim, S. H.
    GYNECOLOGIC ONCOLOGY, 2015, 137 : 152 - 152
  • [49] Conservative management of endometrial hyperplasia or carcinoma with the levonorgestrel intrauterine system may be less effective in morbidly obese patients
    Graul, Ashley
    Wilson, Elise
    Ko, Emily
    Haggerty, Ashley F.
    Reed, Helen
    Koelper, Nathanael
    Kim, Sarah H.
    GYNECOLOGIC ONCOLOGY REPORTS, 2018, 26 : 45 - 48
  • [50] Clinical Predictive Factors of Response to Treatment in Patients Undergoing Conservative Management of Atypical Endometrial Hyperplasia and Early Endometrial Cancer
    Raffone, Antonio
    Travaglino, Antonio
    Flacco, Maria Elena
    Iasevoli, Mara
    Mollo, Antonio
    Guida, Maurizio
    Insabato, Luigi
    Sardo, Attilio Di Spiezio
    Carugno, Jose
    Zullo, Fulvio
    JOURNAL OF ADOLESCENT AND YOUNG ADULT ONCOLOGY, 2021, 10 (02) : 193 - 201
12345